Audiocast: Hysteroscopic tubal occlusion: How new product labeling can be a resource for patient counseling

Dr. Bradley is Professor of Surgery and Vice Chair of Obstetrics and Gynecology at the Women’s Health Institute, and Director, Center for Menstrual Disorders, Fibroids, and Hysteroscopic Services, Cleveland Clinic, Cleveland, Ohio. Dr. Bradley serves on the OBG MANAGEMENT Board of Editors.

Dr. Bradley reports that she has received research or grant support from and is a consultant and speaker for Bayer, is a speaker for Smith & Nephew and Teva, serves on the scientific advisory board for Boston Scientific, is a consultant to Karl Storz, and has received royalties from UpToDate and Elsevier.

Dr. Bradley is Professor of Surgery and Vice Chair of Obstetrics and Gynecology at the Women’s Health Institute, and Director, Center for Menstrual Disorders, Fibroids, and Hysteroscopic Services, Cleveland Clinic, Cleveland, Ohio. Dr. Bradley serves on the OBG MANAGEMENT Board of Editors.

Dr. Bradley reports that she has received research or grant support from and is a consultant and speaker for Bayer, is a speaker for Smith & Nephew and Teva, serves on the scientific advisory board for Boston Scientific, is a consultant to Karl Storz, and has received royalties from UpToDate and Elsevier.

Dr. Bradley is Professor of Surgery and Vice Chair of Obstetrics and Gynecology at the Women’s Health Institute, and Director, Center for Menstrual Disorders, Fibroids, and Hysteroscopic Services, Cleveland Clinic, Cleveland, Ohio. Dr. Bradley serves on the OBG MANAGEMENT Board of Editors.

Dr. Bradley reports that she has received research or grant support from and is a consultant and speaker for Bayer, is a speaker for Smith & Nephew and Teva, serves on the scientific advisory board for Boston Scientific, is a consultant to Karl Storz, and has received royalties from UpToDate and Elsevier.